Uther
Finnrick has tested 85 samples from Uther across 13 products.
Finnrick Vendor Profile
to
Uther
Tracking 13 products
85 total samples tested
Last test 28 Apr 2026
Take Action
Test My Sample
Researcher
Request Full Data Access to the Finnrick database of peptide tests.
Products
| Tests | ||||||||
|---|---|---|---|---|---|---|---|---|
| Product | Rating | Count | Avg | Min | Max | Oldest | Most Recent | |
| Melanotan II | 2 | 9 Oct 2025 | 9 Oct 2025 | |||||
| Mazdutide | 2 | 9 Oct 2025 | 9 Oct 2025 | |||||
| Semaglutide | 3 | 9 Oct 2025 | 29 Dec 2025 | |||||
| PT-141 | 4 | 9 Oct 2025 | 28 Apr 2026 | |||||
| BPC-157 | 11 | 3 Jul 2025 | 6 Mar 2026 | |||||
| GHK-Cu | 7 | 9 Oct 2025 | 28 Apr 2026 | |||||
| Retatrutide | 15 | 3 Jul 2025 | 28 Apr 2026 | |||||
| Ipamorelin | 6 | 9 Oct 2025 | 6 Mar 2026 | |||||
| Cagrilintide | 3 | 9 Oct 2025 | 13 Mar 2026 | |||||
| Survodutide | 4 | 9 Oct 2025 | 23 Apr 2026 | |||||
| CJC-1295 | 6 | 9 Oct 2025 | 7 Mar 2026 | |||||
| Tesamorelin | 7 | 24 Jul 2025 | 25 Mar 2026 | |||||
| Tirzepatide | 15 | 3 Jul 2025 | 28 Apr 2026 | |||||
Some samples were submitted by Uther as part of the Launch with Finnrick vendor support program. Samples are otherwise either acquired by Finnrick directly, or submitted by the public.
Customer Reviews
These indicators of customer satisfaction are based on reports submitted by the public through the Finnrick testing program, and are not verified.
4.8
Based on 22 overall satisfaction reports
Ease of Purchase4.8(22)
Payment Methods4.7(20)
Delivery Speed4.7(21)
Packaging Quality4.5(21)
Customer Service4.8(20)
People who submitted test requests to Finnrick gave Uther an average satisfaction rating of 4.8 out of 5 across 22 reports associated with samples received and tested by Finnrick.
Most recent Uther tests
Samples are tested in commercial labs
85
tests
13
products
Scores
AVGMINMAX
First
3 Jul 2025
Last
28 Apr 2026
| Quantity | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Product | Certificate | Test Score | Label | Batch | Tested | Difference | Purity | Endotoxins | Batch ID | Container | Tested At | Sent By |
| 28 Apr 2026 | PT-141 | View | 10mg | (no batch claim) | 10.3mg | +3.0% | 99.90% | n/a | (no batch ID) | No Label / Black Crimp / Clear Red Cap | Lab E | Public | |
| 28 Apr 2026 | Retatrutide | View | 30mg | 31.5mg | 30.4mg | -3.5% | 99.90% | n/a | RT30-1128 | White Label / Green Crimp / Red Cap | Lab E | Public | |
| 28 Apr 2026 | Retatrutide | View | 20mg | (no batch claim) | 22.8mg | +14.0% | 99.80% | below LOQ | RE20-0115 | White Label / Black Crimp / Blue Cap | Lab E | Public | |
| 28 Apr 2026 | Tirzepatide | View | 60mg | ⚠️ Sample does not contain Tirzepatide | below LOQ | ZE60-0118 | No Label / Silver Crimp / Yellow Cap | Lab E | Public | ||||
| 28 Apr 2026 | GHK-Cu | View | 100mg | (no batch claim) | 117.9mg | +17.9% | 99.90% | n/a | (no batch ID) | No Label / Blue Crimp / Clear Purple Cap | Lab E | Public | |
| 23 Apr 2026 | Survodutide | View | 10mg | (no batch claim) | 10.8mg | +8.0% | 99.90% | n/a | SUR100929 | White Label / Silver Crimp / Clear Red Cap | Lab E | Public | |
| 25 Mar 2026 | Tesamorelin | View | 20mg | (no batch claim) | 20.6mg | +3.0% | 99.70% | low | TE20-0303 | No Label / Blue Crimp / Green Cap | Lab G | Public | |